WAKE FOREST UNIVERSITY HEALTH SCIENCES for WAKE FOREST UNIVERSITY HEALTH SCIENCES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
"Coronavirus Aid, Relief and Economic Security (CARES) Act implementation";
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOANNE C RUHLAND | — |
Health Issues HCR
"Consolidated Relief Act of 2020," (H.R. 133), $900 billion in COVID-19 relief, 42CFR Part 2 provisions; "COVID-19 Surveillance";
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOANNE C RUHLAND | — |
Medicare/Medicaid MMM
CMS proposed Medicaid Fiscal Accountability Regulation (MFAR); Presidents FY21 budget request Medicare and Medicaid reductions; Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, Families First Coronavirus Response Act, Coronavirus Aid, Relief and Economic Security (CARES) Act implementation; Hospital Price Transparency; drug pricing; proposed 340B program changes. Consolidated Relief Act of 2020, (H.R. 133), including an increase in the number of Medicare-supported graduate medical education (GME) positions, surprise billing legislation, Medicaid Disproportionate Share (DSH) cut delay, and funding for other healthcare extenders.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOANNE C RUHLAND | — |
Medical/Disease Research/Clinical Labs MED
Consolidated Relief Act of 2020, (H.R. 133), FY 21 governmental funding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOANNE C RUHLAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.